DUBLIN, September 18, 2017 /PRNewswire/ --
The "Global Cancer Photodynamic Therapy Market & Cancer Photosensitisers Clinical Trial Outlook 2023" report has been added to Research and Markets' offering.
The photodynamic therapy market is currently segmented into four divisions of acne, cancer, atherosclerosis and psoriasis with acne and cancer currently leading with majority of research and development being focused in these aspects of the photodynamic therapy due to their steep demand.
Recently, the Photodynamic therapy for various types of cancer like breast cancer, head and neck cancer and lung cancer has been receiving increased attention due to its innovative and noninvasive feature which is currently in high demand globally , that has further led to a steady growth in the photodynamic therapy market.
Key Topics Covered:
1. An Introductory Insight into Photodynamic Cancer Therapy
- History & Evolution of the Photodynamic Cancer Therapy
2. Photodynamic Therapy - A Breakthrough in Modern Cancer Therapy
- Dire Need for Photodynamic Therapy in Cancer Treatment - An Insight into its promising features
- Superiority of Photodynamic Cancer Therapy over Traditional Cancer Therapy Method
3. Working Mechanism of the Photodynamic Cancer Therapy- It's Components & Their Role
- Procedure for Photodynamic Therapy
- Photosensitizers (PS) - A Crucial Component of the Photodynamic Therapy
- Oxygen - The Vital Substrate in Photodynamic Therapy
- Light Source - For Safe & Effective Activation of the Photosensitizer
4. Photosensitizer Delivery - For Increased Efficacy of the Photodynamic Therapy
- Organic Nano Particles Photosensitizer Delivery in Photo Dynamic therapy
- Inorganic Nanocarrier of Photosensitizers in Photodynamic Therapy
5. Anti-Tumor Activity of the Photodynamic Therapy
- Direct Tumor Photodynamic Therapy Damage
- Vascular Damage
- Inflammatory & Immune Response
6. Current Status of Various Cancer Treatments Using Photodynamic Therapy
- Non-Melanoma Skin Cancer
- Prostate Cancer
- Breast Cancer
- Brain Tumor
- Lung Cancer
- Head & Neck Cancer
- Oral Lesions & Oesophageal Cancer
- Cervical Cancer
- Colorectal Cancer
- Cancer of the Bile Duct and the Pancreas
7. Photodynamic Combinational Cancer Therapy- Overcoming Current Cancer Therapy Limitations
8. Recent & Promising Advances in the Photodynamic Therapy Segment
- Intracellular Activated Two-Photon photodynamic Therapy for Breast Cancer
- Gold Nano-Clusters: A New Nanotech Innovation for Photodynamic Therapy.
- Photodynamic Therapy & Combinational Therapy using Microbial Adjuvants & Cytokines
9. Current Market Scenario of the Photodynamic Therapy & its Cognizance in the Oncology Segment
- Global Photodynamic Therapy Market Analysis by Device & Essentials
- Regional Analysis of the Photodynamic Therapy Market
10. Favorable Factors for the Growth of Photodynamic Cancer Therapy Market
- Rise in Global Cancer Incident
- Increasing Awareness Regarding Photodynamic Therapy
- Limitations & Failures of Existing Cancer Therapeutics
- Advancement in Research & Development
- Increasing Investment in the Photodynamic Therapy Segment
- Presence of a Strong Clinical Pipeline
- Approvals of the FDA
11. Challenges to the Photodynamic Therapy Market Growth
- Technical & Scientific Limitations
- Dominance of Conventional Therapeutics
- Commercial Challenges
- Patient Specific Issues
- Side Effects Associated with the Photodynamic Therapy
12. Anticipation Regarding the Future of Photodynamic Cancer Therapy
13. Global Cancer Photosensitisers Clinical Pipeline by Company & Phase
- Preclinical
- Phase-I
- Phase-I/II
- Phase-II
- Phase-III
- Registered
14. Marketed Cancer Photosensitisers Clinical
- Hexyl Aminolevulinate (Cevira, Cysview, Hexvix & Hexvix PDT)
- Methyl Aminolevulinate (Metvix, Metvix PDT, Metvixia & Visonac)
- Talaporfin (Aptocine, Aptocine, Aptocine & Litx)
- Aminolevulinic Acid (Litx & Alaglio)
- Aminolevulinic Acid (Alaglio, Effala, Gleolan & Gliolan)
- Porfimer Sodium (Photobarr, Photofrin, Photofrin II & Photofrin PDT)
- Methoxsalen Solution (UVADEX)
- Temoporfin (Foscan)
15. Competitive Landscape
- Theralase Technologies
- Dusa Pharmaceuticals
- Biofrontera AG
- Soligenix
- Coherent
- Lumenis
- Nanoprobes
- PhotoMedex
- Biolitec
- Ambicare Health
- Quest Pharma Tech
- Photolitec
For more information about this report visit https://www.researchandmarkets.com/research/zkm9kj/global_cancer
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
